References
- Barnes TJ Jarvis KL Prestidge CA . Recent advances in porous silicon technology for drug delivery. Ther. Deliv.4 (7), 811–823 (2013).
- Tzur-Balter A Gilert A Massad-Ivanir N Segal E . Engineering porous silicon nanostructures as tunable carriers for mitoxantrone dihydrochloride. Acta Biomater.9 (4), 6208–6217 (2013).
- Hou H Nieto A Ma F Freeman WR Sailor MJ Cheng L . Tunable sustained intravitreal drug delivery system for daunorubicin using oxidized porous silicon. J. Control. Release178, 46–54 (2014).
- Liu D Bimbo LM Makila E et al. Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles. J. Control. Release170 (2), 268–278 (2013).
- Jimenez-Perianez A Abos Gracia B Lopez Relano J et al. Mesoporous silicon microparticles enhance MHC Class I cross-antigen presentation by human dendritic cells. Clin. Dev. Immunol. doi: 10.1155/2013/362163 (2013).
- Rytkonen J Arukuusk P Xu W et al. Porous silicon-cell penetrating peptide hybrid nanocarrier for intracellular delivery of oligonucleotides. Mol. Pharma.11 (2), 382–390 (2014).
- Nan K Ma F Hou H Freeman WR Sailor MJ Cheng L . Porous silicon oxide-PLGA composite microspheres for sustained ocular delivery of daunorubicin. Acta Biomater.10 (8), 3505–3512 (2014).
- Hernandez-Montelongo J Naveas N Degoutin S et al. Porous silicon-cyclodextrin based polymer composites for drug delivery applications. Carbohydr. Polym.110, 238–252 (2014).
- Xia B Zhang W Shi J Xiao S-J . A novel strategy to fabricate doxorubicin/bovine serum albumin/porous silicon nanocomposites with pH-triggered drug delivery for cancer therapy in vitro. J. Mater. Chem. B2 (32), 5280–5286 (2014).
- Xia B Zhang W Shi J Xiao S-j . Engineered stealth porous silicon nanoparticles via surface encapsulation of bovine serum albumin for prolonging blood circulation in vivo. ACS Appl. Mater. Interfaces5 (22), 11718–11724 (2013).
- Kinsella J Ananda S Andrew J et al. Enhanced magnetic resonance contrast of iron oxide nanoparticles embedded in a porous silicon nanoparticle host. Proc. SPIE (Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications X), 8594, doi:10.1117/12.2009784 (2013).
- Gizzatov A Key J Aryal S et al. Hierarchically structured magnetic nanoconstructs with enhanced relaxivity and cooperative tumor accumulation. Adv. Funct. Mater.24 (29), 4584–4594 (2014).
- Nissinen T Nakki S Latikka M et al. Facile synthesis of biocompatible superparamagnetic mesoporous nanoparticles for imageable drug delivery. Microporous Mesoporous Mater.195, 2–8 (2014).
- Almeida PV Shahbazi M-A Makila E et al. Amine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors. Nanoscale6 (17), 10377–10387 (2014).
- Serda RE . Particle platforms for cancer immunotherapy. Int. J. Nanomedicine8, 1683–1696 (2013).
- Martinez JO Boada C Yazdi IK et al. Short and long term, in vitro and in vivo correlations of cellular and tissue responses to mesoporous silicon nanovectors. Small9 (9–10), 1722–1733 (2013).
- Huotari A Xu W Monkare J et al. Effect of surface chemistry of porous silicon microparticles on glucagon-like peptide-1 (GLP-1) loading, release and biological activity. Int. J. Pharm.454 (1), 67–73 (2013).
- Wang F Barnes TJ Prestidge CA . Celecoxib confinement within mesoporous silicon for enhanced oral bioavailability. Mesoporous Biomater.1, 1–16 (2014).
- Makila E Ferreira MPA Kivela H et al. Confinement effects on drugs in thermally hydrocarbonized porous silicon. Langmuir30 (8), 2196–2205 (2014).
- Wang F Hui H Barnes TJ Barnett C Prestidge CA . Oxidized mesoporous silicon microparticles for improved oral delivery of poorly soluble drugs. Mol. Pharm.7 (1), 227–236 (2009).